← Leaderboards
Tyler P Korman
Invizyne Technologies, Inc.
$2,204,674
Attributed
$2,204,674
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $718.8K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,204,674 · 2
By mechanism
R44$2,054,674 · 1
R43$150,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Invizyne Technologies, Inc.
Same institution · by research overlap
- John Martin Billingsley$283,805
Others in their field
Other Emerging Leaders on “Natural Products”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
Research focus
Natural ProductsPlant SourcesMetabolic EngineeringMicrobialAnabolismPlantsFaceMembrane ProteinsGlaucomaMicrobeCannabigerolic AcidCannabinoidsInterestEnzymesAcidsCostInflammatory Bowel DiseasesCellsBioactive Natural ProductsEconomic EvaluationHuntington DiseaseDesignCommercializationProduction
Grant awards (7)
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$631,174
R44 · FY2023 · AT · contact PI
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$47,840
R44 · FY2023 · AT · contact PI
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$6,834
R44 · FY2023 · AT · contact PI
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$647,005
R44 · FY2022 · AT · contact PI
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$71,828
R44 · FY2022 · AT · contact PI
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis$649,993
R44 · FY2021 · AT · contact PI
SimplePath: A Cell-free Enzymatic Platform for Cannabinoid Boisynthesis$150,000
R43 · FY2020 · GM · contact PI